Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma PatientsHome » Resources » Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients Learn More